This Project Grant award from the Health Resources and Services Administration (HRSA) under the Maternal and Child Health Federal Consolidated Programs (CFDA 93.110) will lead to a comprehensive approach to improving the Washington newborn screening (NBS) program. The $857,788 award, spanning July 2024 to June 2028, will focus on quality improvement, data management, and strengthening short-term and long-term follow-up systems for the NBS program. Key activities include: 1) Enhancing the efficiency and equity of the NBS program through improved screening, education, specimen collection, and timeliness; and 2) Improving short-term and long-term follow-up systems, emphasizing stakeholder engagement and exploring interoperability. The project aims to significantly enhance the overall effectiveness of the Washington NBS program by setting the stage for improved data management and follow-up procedures for newborn screening disorders.